Price T Rowe Associates Inc. MD Acquires 4,195 Shares of Ingredion Incorporated (NYSE:INGR)

Price T Rowe Associates Inc. MD grew its position in Ingredion Incorporated (NYSE:INGR - Free Report) by 4.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 96,211 shares of the company's stock after buying an additional 4,195 shares during the quarter. Price T Rowe Associates Inc. MD owned 0.15% of Ingredion worth $13,236,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its stake in shares of Ingredion by 1.2% during the fourth quarter. Vanguard Group Inc. now owns 7,285,705 shares of the company's stock valued at $1,002,222,000 after buying an additional 84,863 shares during the period. Pacer Advisors Inc. raised its holdings in shares of Ingredion by 16.5% during the 4th quarter. Pacer Advisors Inc. now owns 1,890,488 shares of the company's stock valued at $260,056,000 after buying an additional 268,389 shares during the period. Geode Capital Management LLC lifted its position in shares of Ingredion by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 1,182,434 shares of the company's stock worth $162,703,000 after purchasing an additional 14,741 shares in the last quarter. Invesco Ltd. boosted its position in Ingredion by 5.7% in the 4th quarter. Invesco Ltd. now owns 870,317 shares of the company's stock valued at $119,721,000 after buying an additional 46,819 shares during the last quarter. Finally, Allianz Asset Management GmbH boosted its stake in shares of Ingredion by 11.9% during the 4th quarter. Allianz Asset Management GmbH now owns 842,763 shares of the company's stock valued at $115,930,000 after buying an additional 89,335 shares during the last quarter. Institutional investors and hedge funds own 85.27% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on INGR shares. Oppenheimer decreased their target price on Ingredion from $167.00 to $155.00 and set an "outperform" rating for the company in a research note on Tuesday, April 22nd. BMO Capital Markets lowered their price objective on shares of Ingredion from $147.00 to $133.00 and set a "market perform" rating on the stock in a research note on Wednesday, February 5th. UBS Group set a $155.00 target price on Ingredion in a report on Tuesday, April 22nd. StockNews.com downgraded shares of Ingredion from a "strong-buy" rating to a "buy" rating in a report on Thursday, February 6th. Finally, Stephens decreased their target price on Ingredion from $155.00 to $150.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 5th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $152.20.

Insider Activity

In other news, CEO James P. Zallie sold 10,815 shares of the firm's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $125.88, for a total value of $1,361,392.20. Following the completion of the transaction, the chief executive officer now owns 34,127 shares in the company, valued at $4,295,906.76. This trade represents a 24.06 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.80% of the company's stock.

Ingredion Stock Performance

INGR traded up $4.57 during trading on Tuesday, reaching $138.20. 833,802 shares of the company's stock were exchanged, compared to its average volume of 469,019. Ingredion Incorporated has a fifty-two week low of $111.54 and a fifty-two week high of $155.44. The company has a quick ratio of 1.69, a current ratio of 2.62 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $8.89 billion, a P/E ratio of 14.23, a PEG ratio of 1.03 and a beta of 0.73. The business has a 50 day moving average price of $131.16 and a 200 day moving average price of $135.53.

Ingredion (NYSE:INGR - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $2.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.49 by $0.48. Ingredion had a net margin of 8.71% and a return on equity of 18.62%. The company's quarterly revenue was down 3.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.08 EPS. As a group, analysts predict that Ingredion Incorporated will post 11.14 earnings per share for the current fiscal year.

Ingredion Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, April 22nd. Stockholders of record on Tuesday, April 1st were given a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date was Tuesday, April 1st. Ingredion's dividend payout ratio is currently 32.96%.

Ingredion Company Profile

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.